Ulf Larsson‐Cohn

1.9k total citations
61 papers, 1.5k citations indexed

About

Ulf Larsson‐Cohn is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Ulf Larsson‐Cohn has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Public Health, Environmental and Occupational Health and 18 papers in Genetics. Recurrent topics in Ulf Larsson‐Cohn's work include Reproductive Health and Contraception (18 papers), Hormonal and reproductive studies (18 papers) and Estrogen and related hormone effects (18 papers). Ulf Larsson‐Cohn is often cited by papers focused on Reproductive Health and Contraception (18 papers), Hormonal and reproductive studies (18 papers) and Estrogen and related hormone effects (18 papers). Ulf Larsson‐Cohn collaborates with scholars based in Sweden, Netherlands and Thailand. Ulf Larsson‐Cohn's co-authors include Lars Wallentin, Lars Fåhraeus, Görán Zador, Elof D.B. Johansson, Carl Gemzell, Mats Hammar, Göran Berg, Stephan Rössner, Jonas Boberg and Lars A. Carlson and has published in prestigious journals such as The Lancet, JAMA and American Journal of Clinical Nutrition.

In The Last Decade

Ulf Larsson‐Cohn

56 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Larsson‐Cohn Sweden 25 728 467 425 310 173 61 1.5k
S.A. Birk United States 22 542 0.7× 367 0.8× 175 0.4× 292 0.9× 278 1.6× 65 1.4k
Göran Cullberg Sweden 18 461 0.6× 288 0.6× 239 0.6× 367 1.2× 78 0.5× 36 916
Veronica A. Ravnikar United States 18 1.2k 1.7× 342 0.7× 929 2.2× 339 1.1× 175 1.0× 31 2.3k
J. W. H. Doar United Kingdom 14 492 0.7× 291 0.6× 129 0.3× 120 0.4× 57 0.3× 28 1.2k
Joanne Hoover United States 15 874 1.2× 292 0.6× 223 0.5× 83 0.3× 88 0.5× 21 1.4k
Adi Mehta Canada 18 715 1.0× 245 0.5× 190 0.4× 322 1.0× 106 0.6× 37 1.7k
V. Anyaoku United Kingdom 21 985 1.4× 381 0.8× 203 0.5× 352 1.1× 288 1.7× 40 1.8k
R. Niththyananthan United Kingdom 14 572 0.8× 375 0.8× 95 0.2× 405 1.3× 98 0.6× 18 1.1k
Anders Frøland Denmark 23 516 0.7× 100 0.2× 428 1.0× 73 0.2× 201 1.2× 68 1.9k
Stein Vaaler Norway 20 712 1.0× 194 0.4× 167 0.4× 167 0.5× 51 0.3× 55 1.3k

Countries citing papers authored by Ulf Larsson‐Cohn

Since Specialization
Citations

This map shows the geographic impact of Ulf Larsson‐Cohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Larsson‐Cohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Larsson‐Cohn more than expected).

Fields of papers citing papers by Ulf Larsson‐Cohn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Larsson‐Cohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Larsson‐Cohn. The network helps show where Ulf Larsson‐Cohn may publish in the future.

Co-authorship network of co-authors of Ulf Larsson‐Cohn

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Larsson‐Cohn. A scholar is included among the top collaborators of Ulf Larsson‐Cohn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Larsson‐Cohn. Ulf Larsson‐Cohn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Egberg, Nils, et al.. (1998). Effects on the hemostatic system and liver function in relation to Implanon® and Norplant®. Contraception. 58(2). 93–98. 44 indexed citations
2.
Larsson‐Cohn, Ulf, Lars Fåhraeus, H. von Schenck, & Lars Wallentin. (1986). Effects On the Lipoprotein Metabolism of an Antiandrogen—Estrogen Oral Contraceptive Drug. Acta Obstetricia Et Gynecologica Scandinavica. 65(2). 125–128. 4 indexed citations
3.
Fåhraeus, Lars, et al.. (1984). Plasma lipoproteins during and after danazol treatment. Acta Obstetricia Et Gynecologica Scandinavica. 63(S123). 133–135. 8 indexed citations
4.
Fåhraeus, Lars & Ulf Larsson‐Cohn. (1982). Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17β to menopausal women. European Journal of Endocrinology. 101(4). 592–596. 31 indexed citations
5.
Larsson‐Cohn, Ulf, Lars Fåhraeus, Lars Wallentin, & Görán Zador. (1982). Effects of the Estrogenicity of Levonorgestrel/Ethinylestradiol Combinations on the Lipoprotein Status. Acta Obstetricia Et Gynecologica Scandinavica. 61(S105). 37–40. 25 indexed citations
6.
Larsson‐Cohn, Ulf, Lars Fåhraeus, Lars Wallentin, & Görán Zador. (1981). Lipoprotein Changes May Be Minimized by Proper Composition of a Combined Oral Contraceptive. Fertility and Sterility. 35(2). 172–179. 75 indexed citations
7.
Larsson‐Cohn, Ulf, Lars Wallentin, & Görán Zador. (1979). Plasma Lipids and High Density Lipoproteins during Oral Contraception with Different Combinations of Ethinyl Estradiol and Levonorgestrel. Hormone and Metabolic Research. 11(7). 437–440. 43 indexed citations
8.
Larsson‐Cohn, Ulf, et al.. (1978). Inhibition of ovulation by gestagens.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 22. 16–22. 4 indexed citations
9.
Dusitsin, N., Monthira Tankeyoon, & Ulf Larsson‐Cohn. (1978). Liver function in Thai women using different types of hormonal contraceptive agents.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 61(7). 381–9. 1 indexed citations
10.
Larsson‐Cohn, Ulf & Lars Wallentin. (1977). Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests.. PubMed. 86(3). 583–96. 27 indexed citations
11.
12.
Larsson‐Cohn, Ulf. (1976). Differences between Capillary and Venous Blood Glucose during Oral Glucose Tolerance Tests. Scandinavian Journal of Clinical and Laboratory Investigation. 36(8). 805–808. 44 indexed citations
13.
Larsson‐Cohn, Ulf, Magne K. Fagerhol, & Ulrich Abildgaard. (1972). Concentration of Antithrombin III During Combined and Progestogen‐Only Oral Contraceptive Treatment. Acta Obstetricia Et Gynecologica Scandinavica. 51(4). 315–317. 6 indexed citations
14.
Larsson‐Cohn, Ulf, Elof D.B. Johansson, & Carl Gemzell. (1971). EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.03 mg OF d-NORGESTREL ON THE PLASMA LEVELS OF PROGESTERONE AND THE URINARY EXCRETION OF OESTROGENS. European Journal of Endocrinology. 66(4). 702–710. 13 indexed citations
15.
Larsson‐Cohn, Ulf. (1971). METABOLIC EFFECTS OF CONTRACEPTIVE STEROIDS WITH SPECIAL REFERENCE TO THE LIPID METABOLISM. European Journal of Endocrinology. 68(1_Supplb). S173–S173. 1 indexed citations
16.
Larsson‐Cohn, Ulf. (1969). The serum alanine aminotransferase activity and the two-hour sulphobromophthalein retention test during daily low-dose gestagen oral contraceptive treatment.. PubMed. 74(5-6). 283–8. 2 indexed citations
17.
Larsson‐Cohn, Ulf. (1968). [Clinical experiences with two sequential oral contraceptive agents].. PubMed. 65(51). 5115–20 passim. 1 indexed citations
18.
Larsson‐Cohn, Ulf. (1967). The 2 hour sulfobromophthalein retention test and the transaminase activity during oral contraceptive therapy. American Journal of Obstetrics and Gynecology. 98(2). 188–193. 12 indexed citations
19.
Larsson‐Cohn, Ulf. (1966). THE TWO‐HOUR SULFOBROMPHTHALEIN RETENTION TEST AND THE TRANSAMINASE ACTIVITY DURING, ORAL CONTRACEPTIVE THERAPY. Acta Obstetricia Et Gynecologica Scandinavica. 45(S9). 37–37. 3 indexed citations
20.
Larsson‐Cohn, Ulf. (1964). [ORAL CONTRACEPTION: PHYSIOLOGY AND A PRELIMINARY ACCOUNT OF OUR OWN CLINICAL MATERIAL].. PubMed. 61. 1328–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S.A. Birk Breakdown of academic impact, for papers by Göran Cullberg Breakdown of academic impact, for papers by Veronica A. Ravnikar Breakdown of academic impact, for papers by J. W. H. Doar Breakdown of academic impact, for papers by Joanne Hoover Breakdown of academic impact, for papers by Adi Mehta Breakdown of academic impact, for papers by V. Anyaoku Breakdown of academic impact, for papers by R. Niththyananthan Breakdown of academic impact, for papers by Anders Frøland Breakdown of academic impact, for papers by Stein Vaaler
Rankless by CCL
2026